CMX-2043

DRUG2 trials

Sponsors

Ischemix, LLC

Conditions

Non STEMIPercutaneous Coronary InterventionStable Coronary Artery DiseaseUnstable Angina

Phase 2

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

CompletedNCT00984802

Ischemix, LLCPercutaneous Coronary Intervention, Stable Coronary Artery Disease

Start: 2010-02-28End: 2011-04-30Updated: 2011-06-20

Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography

CompletedNCT02103959

Ischemix, LLCNon STEMI, Unstable Angina

Start: 2014-06-30End: 2015-12-31Updated: 2016-02-23